These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 34283528

  • 1. [The effectiveness of botulinum therapy of trigeminal neuralgia].
    Mingazova LR, Orlova OR, Soiher MI, Bychenko VG, Komissarova NV.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(6):40-45. PubMed ID: 34283528
    [Abstract] [Full Text] [Related]

  • 2. The Therapeutic Effect of Botulinum Toxin Type A on Trigeminal Neuralgia: Are There Any Differences between Type 1 versus Type 2 Trigeminal Neuralgia?
    Tereshko Y, Valente M, Belgrado E, Dalla Torre C, Dal Bello S, Merlino G, Gigli GL, Lettieri C.
    Toxins (Basel); 2023 Nov 14; 15(11):. PubMed ID: 37999517
    [Abstract] [Full Text] [Related]

  • 3. [Acupuncture and ganglionic local opioid analgesia in trigeminal neuralgia].
    Spacek A, Hanl G, Groiss O, Koinig H, Kress HG.
    Wien Med Wochenschr; 1998 Nov 14; 148(19):447-9. PubMed ID: 10025042
    [Abstract] [Full Text] [Related]

  • 4. Botulinum Toxin as an Effective Treatment for Trigeminal Neuralgia in Surgical Practices.
    Tangney T, Heydari ES, Sheldon BL, Shetty A, Argoff CE, Khazen O, Pilitsis JG.
    Stereotact Funct Neurosurg; 2022 Nov 14; 100(5-6):314-320. PubMed ID: 35944492
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic effect of Botulinum toxin-A in 88 patients with trigeminal neuralgia with 14-month follow-up.
    Li S, Lian YJ, Chen Y, Zhang HF, Ma YQ, He CH, Wu CJ, Xie NC, Zheng YK, Zhang Y.
    J Headache Pain; 2014 Jun 22; 15(1):43. PubMed ID: 24952600
    [Abstract] [Full Text] [Related]

  • 6. Injections of botulinum toxin type a produce pain alleviation in intractable trigeminal neuralgia.
    Allam N, Brasil-Neto JP, Brown G, Tomaz C.
    Clin J Pain; 2005 Jun 22; 21(2):182-4. PubMed ID: 15722812
    [Abstract] [Full Text] [Related]

  • 7. Subcutaneous trigeminal nerve field stimulation for refractory trigeminal pain: a cohort analysis.
    Jakobs M, Unterberg A, Treede RD, Schuh-Hofer S, Ahmadi R.
    Acta Neurochir (Wien); 2016 Sep 22; 158(9):1767-74. PubMed ID: 27372299
    [Abstract] [Full Text] [Related]

  • 8. Acute treatment of trigeminal neuralgia with onabotulinum toxin A.
    Zúñiga C, Piedimonte F, Díaz S, Micheli F.
    Clin Neuropharmacol; 2013 Sep 22; 36(5):146-50. PubMed ID: 24045604
    [Abstract] [Full Text] [Related]

  • 9. Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia?
    Shehata HS, El-Tamawy MS, Shalaby NM, Ramzy G.
    J Headache Pain; 2013 Nov 19; 14(1):92. PubMed ID: 24251833
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic efficacy and safety of Botulinum Toxin A Therapy in Trigeminal Neuralgia: a systematic review and meta-analysis of randomized controlled trials.
    Morra ME, Elgebaly A, Elmaraezy A, Khalil AM, Altibi AM, Vu TL, Mostafa MR, Huy NT, Hirayama K.
    J Headache Pain; 2016 Dec 19; 17(1):63. PubMed ID: 27377706
    [Abstract] [Full Text] [Related]

  • 11. Botulinum toxin type A as an alternative way to treat trigeminal neuralgia: a systematic review.
    Ostrowski H, Roszak J, Komisarek O.
    Neurol Neurochir Pol; 2019 Dec 19; 53(5):327-334. PubMed ID: 31397877
    [Abstract] [Full Text] [Related]

  • 12. Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial.
    Zhang H, Lian Y, Ma Y, Chen Y, He C, Xie N, Wu C.
    J Headache Pain; 2014 Sep 27; 15(1):65. PubMed ID: 25263254
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Neuromodulators for Atypical Facial Pain and Neuralgias: A Systematic Review and Meta-Analysis.
    Do TM, Unis GD, Kattar N, Ananth A, McCoul ED.
    Laryngoscope; 2021 Jun 27; 131(6):1235-1253. PubMed ID: 33037835
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of multiple sclerosis-related trigeminal neuralgia with onabotulinumtoxinA.
    Asan F, Gündüz A, Tütüncü M, Uygunoğlu U, Savrun FK, Saip S, Siva A.
    Headache; 2022 Nov 27; 62(10):1322-1328. PubMed ID: 36437599
    [Abstract] [Full Text] [Related]

  • 17. Atrophic changes in the trigeminal nerves of patients with trigeminal neuralgia due to neurovascular compression and their association with the severity of compression and clinical outcomes.
    Leal PR, Barbier C, Hermier M, Souza MA, Cristino-Filho G, Sindou M.
    J Neurosurg; 2014 Jun 27; 120(6):1484-95. PubMed ID: 24745706
    [Abstract] [Full Text] [Related]

  • 18. Pilot Study of Injection of OnabotulinumtoxinA Toward the Sphenopalatine Ganglion for the Treatment of Classical Trigeminal Neuralgia.
    Crespi J, Bratbak D, Dodick DW, Matharu M, Jamtøy KA, Tronvik E.
    Headache; 2019 Sep 27; 59(8):1229-1239. PubMed ID: 31342515
    [Abstract] [Full Text] [Related]

  • 19. Trigeminal neuralgia and neuropathy in large sporadic vestibular schwannomas.
    Neff BA, Carlson ML, O'Byrne MM, Van Gompel JJ, Driscoll CLW, Link MJ.
    J Neurosurg; 2017 Nov 27; 127(5):992-999. PubMed ID: 28084915
    [Abstract] [Full Text] [Related]

  • 20. A Retrospective Analysis of Medical Management Strategies for Trigeminal Neuralgia: An Institutional Review.
    Murugesan I, T N U, Ramalingam K.
    Cureus; 2024 Sep 27; 16(9):e69258. PubMed ID: 39398659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.